Discovery Life Sciences Revenue and Competitors

We are excited to introduce you to the new Discovery Life Sciencesâ„¢ and our new website www.dls.com! We have merged Conversant Bio, Folio Bio, Phylogeny, and Discovery Life Sciences to create the global market leader in biospecimen analysis and procurement for the pharmaceutical, biotechnology, and diagnostics industries. We know that you will see increased value in Discovery Life Sciences' vast bioanalytics capabilities, consultative services, and deep scientific expertise to quickly bring innovative solutions to your most complex research questions. We will continue to be driven by science, and we will continue to engage with you to overcome your obstacles, achieve your goals and reach a faster end result. Our expanded capabilities now include custom research services in: - Histopathology - Flow Cytometry - Custom Cell Isolations and Processing - Genomic Characterizations Biospecimens Our biospecimen catalog now includes normal, suspect, and disease-state samples, comprising rare diseases and racially and ethnically diverse exemplars, with a particular emphasis in oncology; cardiology; neurology; and infectious, inflammatory, and autoimmune diseases. Moving forward together, we are better positioned to support a broader range of research needs and deliver high-quality solutions. Feel free to reach out if you have any questions about the merger or our expanded capabilities. Visit us at www.dls.com